Nutex Health Inc. (NASDAQ:NUTX) Short Interest Up 198.9% in July

Nutex Health Inc. (NASDAQ:NUTX) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 108,500 shares, a growth of 198.9% from the June 30th total of 36,300 shares. Based on an average trading volume of 30,100 shares, the short-interest ratio is currently 3.6 days. Currently, 3.9% of the shares of the stock are short sold.

Insider Buying and Selling

In other news, CEO Thomas T. Vo purchased 4,839 shares of Nutex Health stock in a transaction that occurred on Tuesday, May 28th. The shares were acquired at an average price of $7.00 per share, for a total transaction of $33,873.00. Following the transaction, the chief executive officer now owns 1,805,390 shares of the company’s stock, valued at approximately $12,637,730. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last 90 days, insiders have bought 8,870 shares of company stock worth $58,598. Corporate insiders own 38.52% of the company’s stock.

Institutional Trading of Nutex Health

A number of hedge funds have recently added to or reduced their stakes in the stock. One Plus One Wealth Management LLC lifted its holdings in shares of Nutex Health by 2,017.5% during the first quarter. One Plus One Wealth Management LLC now owns 5,293,720 shares of the company’s stock worth $508,000 after purchasing an additional 5,043,720 shares during the period. Beaird Harris Wealth Management LLC lifted its holdings in shares of Nutex Health by 210.0% during the fourth quarter. Beaird Harris Wealth Management LLC now owns 930,282 shares of the company’s stock worth $167,000 after purchasing an additional 630,168 shares during the period. Truist Financial Corp lifted its holdings in shares of Nutex Health by 86.0% during the fourth quarter. Truist Financial Corp now owns 4,367,317 shares of the company’s stock worth $786,000 after purchasing an additional 2,018,966 shares during the period. Finally, GDS Wealth Management lifted its holdings in shares of Nutex Health by 98.2% during the fourth quarter. GDS Wealth Management now owns 1,110,051 shares of the company’s stock worth $200,000 after purchasing an additional 550,026 shares during the period. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Price Performance

Shares of NASDAQ NUTX traded down $0.01 during trading hours on Thursday, hitting $7.45. 31,195 shares of the stock were exchanged, compared to its average volume of 26,791. Nutex Health has a 1-year low of $4.16 and a 1-year high of $63.00. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.63 and a current ratio of 1.68. The company has a market cap of $37.03 million, a PE ratio of -0.70 and a beta of -0.07. The company’s fifty day simple moving average is $6.17 and its two-hundred day simple moving average is $12.16.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Wednesday, May 8th. The company reported ($0.10) earnings per share for the quarter. Nutex Health had a negative net margin of 15.85% and a negative return on equity of 44.06%. The company had revenue of $67.45 million during the quarter.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.